Xeris Biopharma Holdings, Inc. (XERS) Balance Sheet
As of 2026-06-30 (10-Q), Xeris Biopharma Holdings, Inc. (XERS) reported total assets of $411.9M, total liabilities of $421.6M and shareholders' equity of -$9.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $121.7M. Long-term debt: $252.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XERSXeris Biopharma Holdings, Inc.Follow XERS — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 67.3 | 122.0 | 67.4 | 71.6 | 111.0 | 121.7 | |
| Short-term investments | 35.2 | 0.0 | 5.0 | 0.0 | — | — | |
| Receivables | 17.5 | 30.8 | 39.2 | 40.4 | 51.1 | 58.1 | |
| Inventory | 18.1 | 24.7 | 38.8 | 48.2 | 68.7 | 80.9 | |
| Current assets | 142.6 | 186.8 | 156.3 | 167.7 | 240.3 | 274.8 | |
| Total assets | 304.4 | 344.5 | 322.6 | 323.1 | 383.5 | 411.9 | |
| Current liabilities | 79.0 | 73.6 | 95.2 | 100.4 | 109.6 | 189.6 | |
| Long-term debt | 88.1 | 187.1 | 190.9 | 232.1 | 220.3 | 252.6 | |
| Short-term debt | — | — | 0.0 | 15.1 | 0.0 | 63.8 | |
| Total liabilities | 209.1 | 299.3 | 329.4 | 352.7 | 369.8 | 421.6 | |
| Shareholders' equity | 95.2 | 45.2 | -6.8 | -29.6 | 13.7 | -9.7 |
USD millions · SEC XBRL
Xeris Biopharma Holdings, Inc. — questions
- How much cash does Xeris Biopharma Holdings, Inc. have?
- $121.7M in cash and cash equivalents as of 2026-06-30.
- How much debt does Xeris Biopharma Holdings, Inc. have?
- $252.6M of long-term debt and $63.8M due within a year as of 2026-06-30.
- What are Xeris Biopharma Holdings, Inc.'s total assets?
- $411.9M as of 2026-06-30.
- What is Xeris Biopharma Holdings, Inc.'s shareholders' equity?
- -$9.7M as of 2026-06-30.
Every figure on this page comes from Xeris Biopharma Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.